Evidence map›Paper›PMID 40665936›Full record

ArticleAdvanced healthcare materials2025

Photocrosslinkable Kidney Decellularized Extracellular Matrix-Based Bioink for 3D Bioprinting.

Jaemyung Shin, Nima Tabatabaei Rezaei, Subin Choi, Zhangkang Li, Deok-Ho Kim, Keekyoung Kim

Abstract read
In one paragraph

Article in Advanced healthcare materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jaemyung ShinDepartment of Biomedical Engineering, Schulich School of Engineering, University of Calgary, Calgary, Alberta, T2N 1N4, Canada.
Nima Tabatabaei RezaeiDepartment of Mechanical and Manufacturing Engineering, Schulich School of Engineering, University of Calgary, Calgary, Alberta, T2N 1N4, Canada.ORCID https://orcid.org/0000-0002-4172-1408
Subin ChoiDepartment of Biomedical Engineering, Schulich School of Engineering, University of Calgary, Calgary, Alberta, T2N 1N4, Canada.
Zhangkang LiBasic Medical Research Center, Medical School of Nantong University, Co-Innovation Center of Neuroregeneration, Nantong, Jiangsu, 226001, China.
Deok-Ho KimDepartment of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland, 21218, USA.
Keekyoung KimDepartment of Biomedical Engineering, Schulich School of Engineering, University of Calgary, Calgary, Alberta, T2N 1N4, Canada.ORCID https://orcid.org/0000-0002-7442-7117

Funding

Canada Foundation for Innovation John R. Evans Leaders FundNatural Sciences and Engineering Research Council of Canada RGPIN-2020-04559
6 · The paper itself

Abstract

Three-dimensional bioprinting has emerged as a promising strategy in tissue engineering, enabling the fabrication of biomimetic tissue constructs for regenerative medicine, disease modeling, and drug screening. A key challenge in this field is the development of organ-specific bioinks capable of recapitulating native microenvironments to support cell viability, proliferation, and tissue-specific maturation. In this study, a novel photocrosslinkable bioink derived from methacrylated decellularized porcine kidney extracellular matrix (KdMA) is reported. The decellularization process effectively removed cellular components while preserving key extracellular matrix constituents. The resulting KdMA bioink exhibited favorable rheological properties, including tunable stiffness and rapid photocuring kinetics, making it compatible with both digital light processing-based stereolithography and extrusion-based bioprinting platforms. Encapsulated human embryonic kidney cells maintained high viability and formed multicellular spheroids, demonstrating the bioink's cytocompatibility and structural support. Additionally, the KdMA bioink enabled stable multilayer bioprinting with preserved structural integrity and tunable mechanical properties. These results underscore the utility of KdMA as a kidney-specific bioink and its promise as a versatile platform for advancing renal tissue engineering and organoid maturation.

Indexed as

BioprintingDecellularized Extracellular MatrixExtracellular MatrixInkKidneyPrinting, Three-DimensionalAnimalsCell SurvivalHumansSwineTissue EngineeringTissue ScaffoldsDecellularized Extracellular Matrix3D bioprintingdecellularized extracellular matrixkidney tissue engineeringphotocrosslinkable bioink

Identifiers

PMID40665936
PMCPMC12447028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.